[artículo]
| Título : |
Tiagabine in adult patients with generalized anxiety disorder : Results from 3 randomized, double-blind, placebo-controlled, parallel-group studies |
| Tipo de documento: |
texto impreso |
| Autores: |
Mark H. Pollack, Autor ; Fang Xie, Autor ; Madhukar H. Trivedi, Autor |
| Fecha de publicación: |
2023 |
| Artículo en la página: |
pp. 308-316 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Etiquetas: |
Ansiolíticos, Trastornos de ansiedad, Ensayos Clínicos, Agonistas de GABA, Ácidos Nipecóticos. |
| Resumen: |
The objective of these studies was to evaluate the efficacy and tolerability of tiagabine, a selective γ-aminobutyric acid reuptake inhibitor, in adult patients with generalized anxiety disorder (GAD). Patients with a diagnosis of GAD were enrolled in 1 of 3 randomized, placebo-controlled, 10-week studies. In each study, tiagabine was taken twice daily in divided doses-4, 8, or 12 mg/d in a fixed-dose study and 4-16 mg/d in two flexible-dose trials. |
| Link: |
./index.php?lvl=notice_display&id=30852 |
in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 3 (Junio) . - pp. 308-316
[artículo] Tiagabine in adult patients with generalized anxiety disorder : Results from 3 randomized, double-blind, placebo-controlled, parallel-group studies [texto impreso] / Mark H. Pollack, Autor ; Fang Xie, Autor ; Madhukar H. Trivedi, Autor . - 2023 . - pp. 308-316. Idioma : Inglés ( eng) Idioma original : Inglés ( eng) in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 3 (Junio) . - pp. 308-316
| Etiquetas: |
Ansiolíticos, Trastornos de ansiedad, Ensayos Clínicos, Agonistas de GABA, Ácidos Nipecóticos. |
| Resumen: |
The objective of these studies was to evaluate the efficacy and tolerability of tiagabine, a selective γ-aminobutyric acid reuptake inhibitor, in adult patients with generalized anxiety disorder (GAD). Patients with a diagnosis of GAD were enrolled in 1 of 3 randomized, placebo-controlled, 10-week studies. In each study, tiagabine was taken twice daily in divided doses-4, 8, or 12 mg/d in a fixed-dose study and 4-16 mg/d in two flexible-dose trials. |
| Link: |
./index.php?lvl=notice_display&id=30852 |
|
Tiagabine in adult patients with generalized anxiety disorder en Journal of Clinical Psychopharmacology, Año 2008 - Vol. 28 - No. 3 (Junio)
